Loading…

Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITPα/β

The identification of effective drug targets and the development of bioactive molecules are areas of high need in cancer therapy. The phosphatidylinositol transfer protein alpha/beta isoform (PITPα/β) has been reported to play an essential role in integrating phosphoinositide trafficking and lipid m...

Full description

Saved in:
Bibliographic Details
Published in:Signal transduction and targeted therapy 2023-11, Vol.8 (1), p.428-428, Article 428
Main Authors: Yang, Hange, Zhang, Xiaowei, Wang, Cong, Zhang, Hailong, Yi, Juan, Wang, Kun, Hou, Yanzhe, Ji, Peihong, Jin, Xiaojie, Li, Chenghao, Zhang, Min, Huang, Shan, Jia, Haoyuan, Hu, Kuan, Mou, Lingyun, Wang, Rui
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c436t-d6967ecde89a713adc4cce2aa9e8eda0f4d40c63740239c83c38124b28961c323
container_end_page 428
container_issue 1
container_start_page 428
container_title Signal transduction and targeted therapy
container_volume 8
creator Yang, Hange
Zhang, Xiaowei
Wang, Cong
Zhang, Hailong
Yi, Juan
Wang, Kun
Hou, Yanzhe
Ji, Peihong
Jin, Xiaojie
Li, Chenghao
Zhang, Min
Huang, Shan
Jia, Haoyuan
Hu, Kuan
Mou, Lingyun
Wang, Rui
description The identification of effective drug targets and the development of bioactive molecules are areas of high need in cancer therapy. The phosphatidylinositol transfer protein alpha/beta isoform (PITPα/β) has been reported to play an essential role in integrating phosphoinositide trafficking and lipid metabolism in diverse cellular processes but remains unexplored as a potential target for cancer treatment. Herein, data analysis of clinical cancer samples revealed that PITPα/β expression is closely correlated with the poor prognosis. Target identification by chemical proteomic methods revealed that microcolin H, a naturally occurring marine lipopeptide, directly binds PITPα/β and displays antiproliferative activity on different types of tumour cell lines. Furthermore, we identified that microcolin H treatment increased the conversion of LC3I to LC3II, accompanied by a reduction of the level of p62 in cancer cells, leading to autophagic cell death. Moreover, microcolin H showed preeminent antitumour efficacy in nude mouse subcutaneous tumour models with low toxicity. Our discoveries revealed that by targeting PITPα/β, microcolin H induced autophagic cell death in tumours with efficient anti-proliferating activity, which sheds light on PITPα/β as a promising therapeutic target for cancer treatment.
doi_str_mv 10.1038/s41392-023-01667-2
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_b4ac7eb635484a8dbc024d041126d715</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_b4ac7eb635484a8dbc024d041126d715</doaj_id><sourcerecordid>2889798188</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-d6967ecde89a713adc4cce2aa9e8eda0f4d40c63740239c83c38124b28961c323</originalsourceid><addsrcrecordid>eNp9kU1uFDEUhFsIRKKQC7BAltiwSBP_je1eogiSkYLIIqyt1_abwaOe9mC7I-ZY5CA5E046BMSClS37cz1XVdO8ZvQ9o8KcZslEx1vKRUuZUrrlz5pDThddK5RYPP9rf9Ac57yhtGJC64V82RwI3SlhtD5s4HNwKbo4hJFcnBAgY7zBgcBU4u4brPckjH5ymE4I_sBUMtnFgmMhMJZQpm2cEgFXwk0oe9LvSYG0xhLGNblaXl_d_Ty9u33VvFjBkPH4cT1qvn76eH120V5-OV-efbhsnRSqtF51SqPzaDrQTIB30jnkAB0a9EBX0kvqqgNZLXfOCCcM47LnplPMCS6OmuWs6yNs7C6FLaS9jRDsw0FMawupBDeg7SU4jX3NRhoJxveOcumpZIwrr9miar2btXYpfp8wF7sN2eEwwIhxyrYOpUIxxXVF3_6DbmooY3VaKdPpzjBjKsVnqoadc8LV0wcZtfd92rlPW83Zhz7tvaM3j9JTv0X_9OR3exUQM5Dr1bjG9Gf2f2R_AUrIq1U</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2889798188</pqid></control><display><type>article</type><title>Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITPα/β</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Yang, Hange ; Zhang, Xiaowei ; Wang, Cong ; Zhang, Hailong ; Yi, Juan ; Wang, Kun ; Hou, Yanzhe ; Ji, Peihong ; Jin, Xiaojie ; Li, Chenghao ; Zhang, Min ; Huang, Shan ; Jia, Haoyuan ; Hu, Kuan ; Mou, Lingyun ; Wang, Rui</creator><creatorcontrib>Yang, Hange ; Zhang, Xiaowei ; Wang, Cong ; Zhang, Hailong ; Yi, Juan ; Wang, Kun ; Hou, Yanzhe ; Ji, Peihong ; Jin, Xiaojie ; Li, Chenghao ; Zhang, Min ; Huang, Shan ; Jia, Haoyuan ; Hu, Kuan ; Mou, Lingyun ; Wang, Rui</creatorcontrib><description>The identification of effective drug targets and the development of bioactive molecules are areas of high need in cancer therapy. The phosphatidylinositol transfer protein alpha/beta isoform (PITPα/β) has been reported to play an essential role in integrating phosphoinositide trafficking and lipid metabolism in diverse cellular processes but remains unexplored as a potential target for cancer treatment. Herein, data analysis of clinical cancer samples revealed that PITPα/β expression is closely correlated with the poor prognosis. Target identification by chemical proteomic methods revealed that microcolin H, a naturally occurring marine lipopeptide, directly binds PITPα/β and displays antiproliferative activity on different types of tumour cell lines. Furthermore, we identified that microcolin H treatment increased the conversion of LC3I to LC3II, accompanied by a reduction of the level of p62 in cancer cells, leading to autophagic cell death. Moreover, microcolin H showed preeminent antitumour efficacy in nude mouse subcutaneous tumour models with low toxicity. Our discoveries revealed that by targeting PITPα/β, microcolin H induced autophagic cell death in tumours with efficient anti-proliferating activity, which sheds light on PITPα/β as a promising therapeutic target for cancer treatment.</description><identifier>ISSN: 2059-3635</identifier><identifier>ISSN: 2095-9907</identifier><identifier>EISSN: 2059-3635</identifier><identifier>DOI: 10.1038/s41392-023-01667-2</identifier><identifier>PMID: 37963877</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/154/555 ; 631/92/556 ; 692/4028/67/1059/153 ; Animal models ; Animals ; Autophagy ; Autophagy - genetics ; Cancer Research ; Cancer therapies ; Cell Biology ; Cell death ; Cell Line, Tumor ; Internal Medicine ; Lipid metabolism ; Medicine ; Medicine &amp; Public Health ; Mice ; Oncology ; Pathology ; Phosphatidylinositol ; Phosphatidylinositol transfer protein ; Phospholipid Transfer Proteins - chemistry ; Phospholipid Transfer Proteins - metabolism ; Proteomics ; Therapeutic targets ; Toxicity ; Tumor cell lines ; Tumors</subject><ispartof>Signal transduction and targeted therapy, 2023-11, Vol.8 (1), p.428-428, Article 428</ispartof><rights>The Author(s) 2023</rights><rights>2023. The Author(s).</rights><rights>The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c436t-d6967ecde89a713adc4cce2aa9e8eda0f4d40c63740239c83c38124b28961c323</cites><orcidid>0000-0002-0030-3234 ; 0000-0003-2448-2254</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2889798188/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2889798188?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,37013,44590,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37963877$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Hange</creatorcontrib><creatorcontrib>Zhang, Xiaowei</creatorcontrib><creatorcontrib>Wang, Cong</creatorcontrib><creatorcontrib>Zhang, Hailong</creatorcontrib><creatorcontrib>Yi, Juan</creatorcontrib><creatorcontrib>Wang, Kun</creatorcontrib><creatorcontrib>Hou, Yanzhe</creatorcontrib><creatorcontrib>Ji, Peihong</creatorcontrib><creatorcontrib>Jin, Xiaojie</creatorcontrib><creatorcontrib>Li, Chenghao</creatorcontrib><creatorcontrib>Zhang, Min</creatorcontrib><creatorcontrib>Huang, Shan</creatorcontrib><creatorcontrib>Jia, Haoyuan</creatorcontrib><creatorcontrib>Hu, Kuan</creatorcontrib><creatorcontrib>Mou, Lingyun</creatorcontrib><creatorcontrib>Wang, Rui</creatorcontrib><title>Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITPα/β</title><title>Signal transduction and targeted therapy</title><addtitle>Sig Transduct Target Ther</addtitle><addtitle>Signal Transduct Target Ther</addtitle><description>The identification of effective drug targets and the development of bioactive molecules are areas of high need in cancer therapy. The phosphatidylinositol transfer protein alpha/beta isoform (PITPα/β) has been reported to play an essential role in integrating phosphoinositide trafficking and lipid metabolism in diverse cellular processes but remains unexplored as a potential target for cancer treatment. Herein, data analysis of clinical cancer samples revealed that PITPα/β expression is closely correlated with the poor prognosis. Target identification by chemical proteomic methods revealed that microcolin H, a naturally occurring marine lipopeptide, directly binds PITPα/β and displays antiproliferative activity on different types of tumour cell lines. Furthermore, we identified that microcolin H treatment increased the conversion of LC3I to LC3II, accompanied by a reduction of the level of p62 in cancer cells, leading to autophagic cell death. Moreover, microcolin H showed preeminent antitumour efficacy in nude mouse subcutaneous tumour models with low toxicity. Our discoveries revealed that by targeting PITPα/β, microcolin H induced autophagic cell death in tumours with efficient anti-proliferating activity, which sheds light on PITPα/β as a promising therapeutic target for cancer treatment.</description><subject>631/154/555</subject><subject>631/92/556</subject><subject>692/4028/67/1059/153</subject><subject>Animal models</subject><subject>Animals</subject><subject>Autophagy</subject><subject>Autophagy - genetics</subject><subject>Cancer Research</subject><subject>Cancer therapies</subject><subject>Cell Biology</subject><subject>Cell death</subject><subject>Cell Line, Tumor</subject><subject>Internal Medicine</subject><subject>Lipid metabolism</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mice</subject><subject>Oncology</subject><subject>Pathology</subject><subject>Phosphatidylinositol</subject><subject>Phosphatidylinositol transfer protein</subject><subject>Phospholipid Transfer Proteins - chemistry</subject><subject>Phospholipid Transfer Proteins - metabolism</subject><subject>Proteomics</subject><subject>Therapeutic targets</subject><subject>Toxicity</subject><subject>Tumor cell lines</subject><subject>Tumors</subject><issn>2059-3635</issn><issn>2095-9907</issn><issn>2059-3635</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kU1uFDEUhFsIRKKQC7BAltiwSBP_je1eogiSkYLIIqyt1_abwaOe9mC7I-ZY5CA5E046BMSClS37cz1XVdO8ZvQ9o8KcZslEx1vKRUuZUrrlz5pDThddK5RYPP9rf9Ac57yhtGJC64V82RwI3SlhtD5s4HNwKbo4hJFcnBAgY7zBgcBU4u4brPckjH5ymE4I_sBUMtnFgmMhMJZQpm2cEgFXwk0oe9LvSYG0xhLGNblaXl_d_Ty9u33VvFjBkPH4cT1qvn76eH120V5-OV-efbhsnRSqtF51SqPzaDrQTIB30jnkAB0a9EBX0kvqqgNZLXfOCCcM47LnplPMCS6OmuWs6yNs7C6FLaS9jRDsw0FMawupBDeg7SU4jX3NRhoJxveOcumpZIwrr9miar2btXYpfp8wF7sN2eEwwIhxyrYOpUIxxXVF3_6DbmooY3VaKdPpzjBjKsVnqoadc8LV0wcZtfd92rlPW83Zhz7tvaM3j9JTv0X_9OR3exUQM5Dr1bjG9Gf2f2R_AUrIq1U</recordid><startdate>20231115</startdate><enddate>20231115</enddate><creator>Yang, Hange</creator><creator>Zhang, Xiaowei</creator><creator>Wang, Cong</creator><creator>Zhang, Hailong</creator><creator>Yi, Juan</creator><creator>Wang, Kun</creator><creator>Hou, Yanzhe</creator><creator>Ji, Peihong</creator><creator>Jin, Xiaojie</creator><creator>Li, Chenghao</creator><creator>Zhang, Min</creator><creator>Huang, Shan</creator><creator>Jia, Haoyuan</creator><creator>Hu, Kuan</creator><creator>Mou, Lingyun</creator><creator>Wang, Rui</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0030-3234</orcidid><orcidid>https://orcid.org/0000-0003-2448-2254</orcidid></search><sort><creationdate>20231115</creationdate><title>Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITPα/β</title><author>Yang, Hange ; Zhang, Xiaowei ; Wang, Cong ; Zhang, Hailong ; Yi, Juan ; Wang, Kun ; Hou, Yanzhe ; Ji, Peihong ; Jin, Xiaojie ; Li, Chenghao ; Zhang, Min ; Huang, Shan ; Jia, Haoyuan ; Hu, Kuan ; Mou, Lingyun ; Wang, Rui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-d6967ecde89a713adc4cce2aa9e8eda0f4d40c63740239c83c38124b28961c323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>631/154/555</topic><topic>631/92/556</topic><topic>692/4028/67/1059/153</topic><topic>Animal models</topic><topic>Animals</topic><topic>Autophagy</topic><topic>Autophagy - genetics</topic><topic>Cancer Research</topic><topic>Cancer therapies</topic><topic>Cell Biology</topic><topic>Cell death</topic><topic>Cell Line, Tumor</topic><topic>Internal Medicine</topic><topic>Lipid metabolism</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mice</topic><topic>Oncology</topic><topic>Pathology</topic><topic>Phosphatidylinositol</topic><topic>Phosphatidylinositol transfer protein</topic><topic>Phospholipid Transfer Proteins - chemistry</topic><topic>Phospholipid Transfer Proteins - metabolism</topic><topic>Proteomics</topic><topic>Therapeutic targets</topic><topic>Toxicity</topic><topic>Tumor cell lines</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Hange</creatorcontrib><creatorcontrib>Zhang, Xiaowei</creatorcontrib><creatorcontrib>Wang, Cong</creatorcontrib><creatorcontrib>Zhang, Hailong</creatorcontrib><creatorcontrib>Yi, Juan</creatorcontrib><creatorcontrib>Wang, Kun</creatorcontrib><creatorcontrib>Hou, Yanzhe</creatorcontrib><creatorcontrib>Ji, Peihong</creatorcontrib><creatorcontrib>Jin, Xiaojie</creatorcontrib><creatorcontrib>Li, Chenghao</creatorcontrib><creatorcontrib>Zhang, Min</creatorcontrib><creatorcontrib>Huang, Shan</creatorcontrib><creatorcontrib>Jia, Haoyuan</creatorcontrib><creatorcontrib>Hu, Kuan</creatorcontrib><creatorcontrib>Mou, Lingyun</creatorcontrib><creatorcontrib>Wang, Rui</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Signal transduction and targeted therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Hange</au><au>Zhang, Xiaowei</au><au>Wang, Cong</au><au>Zhang, Hailong</au><au>Yi, Juan</au><au>Wang, Kun</au><au>Hou, Yanzhe</au><au>Ji, Peihong</au><au>Jin, Xiaojie</au><au>Li, Chenghao</au><au>Zhang, Min</au><au>Huang, Shan</au><au>Jia, Haoyuan</au><au>Hu, Kuan</au><au>Mou, Lingyun</au><au>Wang, Rui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITPα/β</atitle><jtitle>Signal transduction and targeted therapy</jtitle><stitle>Sig Transduct Target Ther</stitle><addtitle>Signal Transduct Target Ther</addtitle><date>2023-11-15</date><risdate>2023</risdate><volume>8</volume><issue>1</issue><spage>428</spage><epage>428</epage><pages>428-428</pages><artnum>428</artnum><issn>2059-3635</issn><issn>2095-9907</issn><eissn>2059-3635</eissn><abstract>The identification of effective drug targets and the development of bioactive molecules are areas of high need in cancer therapy. The phosphatidylinositol transfer protein alpha/beta isoform (PITPα/β) has been reported to play an essential role in integrating phosphoinositide trafficking and lipid metabolism in diverse cellular processes but remains unexplored as a potential target for cancer treatment. Herein, data analysis of clinical cancer samples revealed that PITPα/β expression is closely correlated with the poor prognosis. Target identification by chemical proteomic methods revealed that microcolin H, a naturally occurring marine lipopeptide, directly binds PITPα/β and displays antiproliferative activity on different types of tumour cell lines. Furthermore, we identified that microcolin H treatment increased the conversion of LC3I to LC3II, accompanied by a reduction of the level of p62 in cancer cells, leading to autophagic cell death. Moreover, microcolin H showed preeminent antitumour efficacy in nude mouse subcutaneous tumour models with low toxicity. Our discoveries revealed that by targeting PITPα/β, microcolin H induced autophagic cell death in tumours with efficient anti-proliferating activity, which sheds light on PITPα/β as a promising therapeutic target for cancer treatment.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>37963877</pmid><doi>10.1038/s41392-023-01667-2</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-0030-3234</orcidid><orcidid>https://orcid.org/0000-0003-2448-2254</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2059-3635
ispartof Signal transduction and targeted therapy, 2023-11, Vol.8 (1), p.428-428, Article 428
issn 2059-3635
2095-9907
2059-3635
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_b4ac7eb635484a8dbc024d041126d715
source Publicly Available Content Database; PubMed Central; Springer Nature - nature.com Journals - Fully Open Access
subjects 631/154/555
631/92/556
692/4028/67/1059/153
Animal models
Animals
Autophagy
Autophagy - genetics
Cancer Research
Cancer therapies
Cell Biology
Cell death
Cell Line, Tumor
Internal Medicine
Lipid metabolism
Medicine
Medicine & Public Health
Mice
Oncology
Pathology
Phosphatidylinositol
Phosphatidylinositol transfer protein
Phospholipid Transfer Proteins - chemistry
Phospholipid Transfer Proteins - metabolism
Proteomics
Therapeutic targets
Toxicity
Tumor cell lines
Tumors
title Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITPα/β
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A05%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Microcolin%20H,%20a%20novel%20autophagy%20inducer,%20exerts%20potent%20antitumour%20activity%20by%20targeting%20PITP%CE%B1/%CE%B2&rft.jtitle=Signal%20transduction%20and%20targeted%20therapy&rft.au=Yang,%20Hange&rft.date=2023-11-15&rft.volume=8&rft.issue=1&rft.spage=428&rft.epage=428&rft.pages=428-428&rft.artnum=428&rft.issn=2059-3635&rft.eissn=2059-3635&rft_id=info:doi/10.1038/s41392-023-01667-2&rft_dat=%3Cproquest_doaj_%3E2889798188%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c436t-d6967ecde89a713adc4cce2aa9e8eda0f4d40c63740239c83c38124b28961c323%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2889798188&rft_id=info:pmid/37963877&rfr_iscdi=true